2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium
Myelodysplastic Syndromes (MDS) continue to pose significant challenges in hematologic oncology. Advancing treatment strategies for MDS hinges on a deeper understanding of the biological mechanisms governing hematopoietic stem cell function in both normal and stress conditions. To address this, the upcoming MDS symposium aims to bring together global experts specializing in hematopoiesis and MDS. This […]